Discover 1,668 paid clinical trials in Durham, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,668
A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
for
Meningioma
Location: Durham NC, New York NY, Indianapolis IN, New Haven CT,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07533942
Phase 2, Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)
for
Locally Advanced Basal Cell Carcinoma
Location: Durham NC, Atlanta GA, Tampa FL, Houston TX
Sponsor: Philogen S.p.A.
Sex: All
Age: 18+
Code: NCT07227350
Phase 2, Recruiting
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
for
Core Binding Factor Acute Myeloid Leukemia
Location: Durham NC, Richmond VA, Boiling Springs SC, Greer SC,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT06917911
Phase 2, Recruiting
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
for
Aortic Arch Dissection, Aortic Arch Aneurysm
Location: Durham NC, Chapel Hill NC, Washington D.C. DC,
Sponsor: W.L.Gore & Associates
Sex: All
Age: 18+
Code: NCT07166133
Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
for
Endometrial Adenocarcinoma,
Location: Durham NC, Raleigh NC, Richmond VA, Charlottesville VA,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT05112601
Phase 2, Recruiting
Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy
for
Bladder Cancer
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06986304
Recruiting
A Study of PHN-012 in Patients With Advanced Solid Tumors
for
Colon Cancer, Pancreatic Cancer, Lung Cancer (NSCLC),
Location: Durham NC, Fairfax VA, Washington D.C. DC, Nashville TN,
Sponsor: Pheon Therapeutics
Sex: All
Age: 18+
Code: NCT07127874
Phase 1, Recruiting
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)